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Abstract. Objective: Prior studies addressing the
incidence of acute myocardial infarction (AMI) in pa-
tients with cocaine-associated chest pain have found
divergent results. Previous prospective studies, which
found approximately a 6% incidence of AMI, have
been criticized for selection bias. This study sought to
determine the rate of AMI in patients with cocaine-
associated chest pain. Methods: All patients seen in
an urban university-affiliated hospital between July
1996 and February 1998 were identified by ICD-9
medical records search for cocaine use and chest pain/
acute coronary syndromes. In this system, all faculty
admit all patients with cocaine-associated chest pain
for at least 23-hour observation periods. Data col-
lected included demographics, medical and cocaine
use history, presenting characteristics, hospital
course, cardiovascular complications, and diagnostic
tests using a 119-item closed-question data instru-
ment with high interrater reliability. The main out-
come measure was AMI according to World Health
Organization (WHO) criteria. Results: There were
250 patients identified with a mean age of 33.5 6 8.5
years; 77% were male; 84% were African American.
Of 196 patients tested, 185 had cocaine or cocaine
metabolites in the urine (94%). The incidence of car-
diac risk factors were: hypercholesterolemia, 8%; di-
abetes, 6%; family history, 34%; hypertension, 26%;
tobacco use, 77%; prior MI, 6%; and prior chest pain,
40%. Seventy-seven percent admitted to cocaine use
in the preceding 24 hours: crack, 85%; IV, 2%; nasal,
6%. Twenty-five patients (10%) had electrocardio-
graphic evidence of ischemia. A total of 15 patients
experienced an AMI (6%; 95% CI = 4.1% to 8.9%) us-
ing WHO criteria. Complications were infrequent:
bradydysrrhythmias, 0.4%; congestive heart failure,
0.4%; supraventricular tachycardia, 1.2%; sustained
ventricular tachycardia, 0.8%. Conclusion: The inci-
dence of AMI was 6% in patients with cocaine-asso-
ciated chest pain. This result is identical to that
found in prior prospective studies. Key words: co-
caine; acute coronary syndrome; acute myocardial in-
farction; emergency department; electrocardiogram.
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COCAINE use is associated with a 24-fold in-creased risk of myocardial infarction during
the hour immediately after use.1 Acute myocardial
infarction (AMI) due to cocaine occurs in patients
with and without diseased coronary arteries.2–4 Al-
though recent data suggest that cocaine-associated
chest pain is infrequently ischemic in nature,5
chest pain remains the most frequent cocaine-as-
sociated emergency department (ED) complaint.6
Previous studies have found a widely divergent in-
cidence of AMI in patients with cocaine-associated
chest pain, largely due to selection bias.7–10 The
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COCHPA (Cocaine Associated Chest Pain) trial
was the largest multicenter study to prospectively
evaluate the incidence of cocaine-associated myo-
cardial infarction.11 That study determined the
prevalence to be 6%.11
The purpose of this study was to determine the
frequency of AMI in patients presenting to the ED
with cocaine-associated chest pain syndromes. The
study ED had a clear-cut widely-adhered-to policy
of admitting all patients with cocaine-associated
chest pain syndrome. As a result, the uniform clin-
ical pathway for management of these patients
is a useful setting to determine the incidence of
AMI without the selection bias observed in prior
studies.
METHODS
Study Design. This was a retrospective cohort
study of patients with chest pain in the setting of
recent cocaine use. The hospital’s institutional re-
view board approved this study.
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TABLE 1. Demographic and Historical Characteristics of the
Study Patients
Age—mean 6 SD (years) 33.5 6 8.5
Gender—male 192 (77%)
Race







Family history of coronary artery disease 86 (34%)
Diabetes mellitus 14 (6%)
Tobacco use 192 (77%)
Past medical problems
Chest pain 100 (40%)
Myocardial infarction 16 (6%)
Congestive heart failure 4 (2%)
Arrhythmias 2 (1%)
Study Setting and Population. Patients who
presented to an urban university-affiliated trauma
center with an annual ED census of 55,000 were
eligible for enrollment. It was departmental policy
during the study period that all ED faculty admit
all patients with cocaine-associated chest pain for
a period of at least 23 hours. A computer-assisted
medical records search was performed to identify
patients presenting to the ED between July 1,
1996, and February 28, 1998. Patients were iden-
tified by cross-referencing the International Clas-
sification of Diseases, Ninth Revision (ICD-9) codes
for chest pain and myocardial infarction with those
for cocaine and/or drug abuse. This list of patients
was then compared with an ED log that included
all admitted patients, to ensure appropriate cap-
ture. Patients were included in the study if they
had a documented history of cocaine use within the
week prior to presentation or a urine toxicology
screen that revealed cocaine or cocaine metabo-
lites; had a chief complaint of anterior, precordial,
or left-sided chest discomfort less than 12 hours in
duration; and were aged 18 years or older.
Study Protocol. All aspects of the medical record
were reviewed to obtain information for documen-
tation using a previously described closed-question
data collection instrument with excellent interra-
ter reliability for all predictor and outcome varia-
bles.12 Emergency physicians maintained the op-
tion of using a template for ‘‘chest pain’’ complete
with risk factors and chest pain characteristics
that otherwise may have been difficult to retrieve
in a retrospective manner. In cases where reports
were dictated and information was missing, docu-
mentation from the cardiologist’s consultation and
houseofficer history and physical examinations
were utilized. For the minority of cases with miss-
ing demographic information despite these re-
trieval methods, the private physician was con-
tacted and questioned regarding specific missing
information. Demographic data included the age,
sex, and ethnic group. Historical items noted were
the cardiac risk factors, past cardiac history, pre-
vious chest pain, and prescription medication use.
The time of last cocaine use, route of use, and re-
sults of urine toxicology (if sent for toxicologic anal-
ysis) were also recorded.
Chest pain was characterized by duration, qual-
ity, and location. Associated symptoms of nausea,
vomiting, dyspnea, syncope, diaphoresis, or palpi-
tations were recorded if documented. The pres-
ences of hypertension, hypotension, bradycardia,
tachycardia, and fever at presentation were noted.
The initial electrocardiogram (ECG) was clas-
sified into one of six categories using a previously
described closed question format.13 The categories
were normal; nonspecific, including early repolar-
ization abnormalities; abnormal but not diagnostic
of ischemia; ischemia; or suggestive of acute myo-
cardial infarction.
Cardiac isoenzyme levels were obtained for all
patients upon presentation, and then at eight-hour
intervals for a total of 24 hours. The presence or
absence of myocardial infarction was defined by
World Health Organization (WHO) criteria,14 with
creatine kinase–MB (CK-MB) enzyme levels twice
the institutional normal value, with a typical rise
and fall. In addition, AMI was classified as Q-wave
or non-Q-wave and by location according to the
ECG.
The hospital course and occurrence and timing
of complications such as congestive heart failure,
ventricular tachycardia, supraventricular tachy-
dysrythmias, and bradydysrythmias were re-
corded.
Data Analysis. Data were entered in Microsoft
Access 97 (Microsoft, Inc., Redmond, WA) and im-
ported into SPSS for Windows 9.0 (SPSS Inc., Chi-
cago, IL) for statistical analysis. Continuous vari-
ables are reported as means 6 SD. Categorical
variables are reported as the percentage frequency
of occurrence. Ninety-five percent confidence inter-
vals are reported for our main outcome, presence
of AMI.
RESULTS
We identified 259 patients with cocaine-associated
chest pain. Nine patients were discharged from the
ED despite a protocol requiring admission. The re-
maining 250 patients composed the study group.
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TABLE 2. Chest Pain Characteristics
Location
Substernal 191 (76%)
Left-sided only 33 (13%)








Pleuritic component 27 (11%)
Associated symptoms






TABLE 3. Vital Signs at the Time of Presentation
Systolic blood pressure
>140 mm Hg 59 (24%)
91–139 mm Hg 190 (76%)
<90 mm Hg 1 (0.4%)
Diastolic blood pressure
>90 mm Hg 38 (15%)
#90 mm Hg 212 (85%)
Pulse
>100 beats/min 40 (16%)
60–100 beats/min 205 (82%)
<60 beats/min 5 (2%)
Respiratory rate
>25 breaths/min 10 (4%)
10–25 breaths/min 240 (96%)
<10 breaths/min 0
Temperature > 387C 4 (2%)
The nine patients who excluded from the study did
not differ significantly from admitted subjects
based on age, gender, ethnicity, or cardiac risk fac-
tors. Although the subsequent complication rate of
the nine patients who were discharged is un-
known, all nine were known to be alive at the con-
clusion of the study period.
The mean age of the study patients was 33.5 6
8.5 years. There were 192 men (77%) and 58
women (23%). The racial distribution was African
American, 208 patients (84%), White, 24 patients
(10%), Hispanic, three patients (1%), and other/un-
known, 6%. The patients had a mean of 1.5 6 1.1
traditional cardiac risk factors, with tobacco being
the most common risk factor. Demographic char-
acteristics and cardiac risk factors are summarized
in Table 1.
All patients either admitted to using cocaine
within seven days of presentation or had cocaine
metabolites in the urine. Precise historical data re-
garding cocaine use were available for all but three
patients. The most recent use of cocaine was
within the preceding 24 hours in 193 patients
(78%) and within the preceding four hours in 57
patients (22%). Of the 196 patients who had urine
toxicologic studies performed, 185 (94%) were
found to have cocaine or cocaine metabolites. Co-
caine was most commonly used through inhalation
of crack (91%).
The location and quality of chest pain and fre-
quency of associated symptoms are summarized in
Table 2. Most patients had substernal pain and
most described their pain as pressure/squeezing or
tightness, although atypical presentations were
also common. The most common associated symp-
tom was dyspnea, but diaphoresis and nausea oc-
curred in more than a fourth of the patients.
Most patients had a normal blood pressure,
pulse, respiratory rate, and temperature. Only
24% had systolic hypertension, 15% had diastolic
hypertension, and 16% were tachycardic. The re-
mainder of the presenting vital signs are summa-
rized in Table 3.
Normal ECGs were obtained for only 67 pa-
tients (27%). One hundred twenty-five patients
had nonspecific changes (50%), of whom 41 (34%)
had early repolarization changes. Thirty-three pa-
tients (13%) had abnormal but nondiagnostic
ECGs; six patients had ischemia known to be old
(2%); ten patients (4%) had ECGs with ischemia
not known to be old; and nine patients (4%) had
ECGs suggestive of AMI.
Myocardial infarction was diagnosed in 15 pa-
tients (6%: 95% CI = 3.1% to 8.9%). Nine patients
had initial ECGs consistent with AMI, four pa-
tients had ischemic changes, and two patients had
normal or nondiagnostic ECGs. All patients diag-
nosed as having AMI had at least one elevation in
CK-MB to more than two times the upper limit of
normal, and all met standard WHO criteria for di-
agnosis of AMI. Eight AMIs (53%) were anterior in
location, six were inferior, and in one the location
was indeterminate. Nine of the AMIs (60%) were
Q-wave infarctions.
Twenty-four patients were initially admitted to
the coronary care unit (CCU). They had a mean
CCU length of stay of 2.7 6 1.9 days. The mean
total hospital stay for all patients was 2.2 6 2.0
days. All 250 patients survived until discharge.
Complications were infrequent. They included
bradydysrythmias in one patient (0.4%), conges-
tive heart failure in one patient (0.4%), supraven-
tricular tachycardia in three patients (1.2%), and
sustained ventricular tachycardia in two patients
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(0.8%). No complication occurred more than 12
hours after ED arrival.
DISCUSSION
Previous studies that have sought to determine the
incidence of cocaine-associated myocardial infarc-
tion have been limited by selection bias. Retro-
spective studies have found an incidence of AMI
ranging from 0% to 31%.7–9 Two prospective stud-
ies have also been criticized for selection bias; how-
ever, the incidence of AMI in both studies was 5–
6%.10,11 The present study was a retrospective case
series, but it occurred in a hospital with a uniform
admission practice for all patients with cocaine-as-
sociated chest pain, decreasing the likelihood of se-
lection bias.
Zimmerman et al. found that three of 48 co-
caine-associated chest pain patients (6%) who were
admitted to the CCU sustained an AMI.7 Gitter et
al. reported no AMI in their cohort of 101 cocaine-
associated chest pain patients admitted to moni-
tored beds.8 Furthermore, 47 of the 101 patients
(46.5%) in the Gitter study had incomplete cardiac
marker testing, and ten patients had no enzyme
tests performed. In contrast, Amin et al. found that
22 of 70 patients (31%) admitted with cocaine use
and chest pain had sustained an AMI.9 The au-
thors did not enroll ED patients who were dis-
charged home, selecting more acutely ill patients
for study enrollment. Amin et al. also reported that
the average time from cocaine use to the onset of
chest pain was 18 hours. Therefore, the apparent
association between cocaine use and myocardial
infarction may have simply reflected a high prev-
alence of cocaine use in the community, and not
necessarily a cause-and-effect relationship.
Three prospective studies have addressed the
incidence of AMI in patients with cocaine-associ-
ated chest pain. Tokarski et al. found that eight of
42 patients (19%) with cocaine-associated chest
pain and normal or nonspecific ECGs had elevated
cardiac markers.10 However, they enrolled a con-
venience sample, and patients with ischemic ECGs
were excluded. Several patients in this cohort had
CK levels that returned to baseline after the first
set of markers was elevated, making interpreta-
tion of their data difficult. Only 5% of patients in
this study actually met WHO criteria for AMI.
The prospective multicenter study of patients
with cocaine-associated chest pain (COCHPA) was
specifically designed to reduce the likelihood of se-
lection bias.11 Patients were prospectively enrolled
regardless of ED disposition at six municipal hos-
pital sites. They found the incidence of AMI to be
6% in patients with cocaine-associated chest pain.
Although the study was designed to eliminate se-
lection bias, it has been criticized because some of
the participating sites had lower-than-expected en-
rollment rates and the study methodology did not
have methods to ensure that all potential study
subjects were captured.
Kontos et al. evaluated a cohort of patients with
cocaine-associated chest pain with resting sesta-
mibi imaging.5 They found that six of 69 (8.5%) pa-
tients admitted to the CCU sustained an AMI;
while only 2.5% of their whole cohort of 241 pa-
tients sustained an AMI. Moreover, negative rest-
ing sestamibi imaging predicted an excellent 30-
day survival. The authors report that myocardial
ischemia is infrequently the cause of cocaine-as-
sociated chest pain in patients who undergo early
perfusion imaging, suggesting that discharge may
be a possible alternative to routine admission in
low-risk patients with normal perfusion scans.5
LIMITATIONS AND FUTURE QUESTIONS
The present study found the incidence of AMI in
patients with cocaine-associated chest pain to be
6%. Since departmental policy during the study pe-
riod mandated hospital admission for patients pre-
senting with a chief complaint of chest pain with
cocaine use, we believe that the sample presented
is representative of the patient population. We
were able to screen ED logs to identify patients
who may have been discharged from the ED in con-
tradistinction to the ED policy. Only nine such pa-
tients were identified, and they had similar dem-
ographic and clinical characteristics to those of the
patients included in the study group. Although ret-
rospective chart review is inherently subject to
some limitations, we used a data collection instru-
ment that has been shown to have excellent inter-
rater reliability for both predictor and outcome
variables.12
Our criteria specifically required chest pain as
a chief complaint, in addition to recent cocaine use.
Therefore, it is possible that patients presenting
without chest pain, yet having symptoms consis-
tent with ischemia (e.g., dyspnea, palpitations,
shortness of breath), were missed. In addition, we
cannot be certain that coding errors did not occur.
However, all charts with an ICD-9 code for AMI,
both with and without cocaine use, were reviewed
for the 19-month study period to minimize over- or
undercoding.
During the study period, it was departmental
policy that toxicologic screens were included as
part of the cardiac profile for patients #50 years
of age without traditional risk factors. These cri-
teria were selected because previous studies have
shown that cocaine use in patients >50 years of age
who present to the ED with chest pain is only 2%.15
Therefore, it is possible that a small number of pa-
tients >50 years of age with chest pain who used
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cocaine were not captured. We assume that the 6%
of patients who admitted to cocaine use but had a
negative toxicologic screen either purchased a mis-
labeled or heavily adulterated substance, or pre-
sented within seven days of use, but beyond the
sensitivity window for the assay to capture the me-
tabolite.
We used the WHO criteria for diagnosis of AMI,
and all patients with an ultimate diagnosis of AMI
had CK-MB elevations to higher than 20 IU/L, al-
though our criteria required only two times nor-
mal, or 10 IU/L. Therefore, we cannot be certain
that a very small number of patients who sus-
tained non-Q-wave myocardial infarctions were
missed. Our patient composition was similar to
prior studies of this patient population. They were
young, predominantly male (76%), cigarette smok-
ers (77%), with chronic cocaine abuse.5–12 Other
than tobacco use, traditional risk factors for coro-
nary artery disease were present less frequently
than among patients with chest pain presumed to
be of ischemic origin.4,7,9,16
Although low-risk groups of traditional patients
who may be safely admitted to intermediate care
units have been identified,17 a group of cocaine-as-
sociated chest pain patients who can be safely re-
leased from the ED based on explicit criteria has
not been validated.18 Hollander et al. have sug-
gested that patients without ischemic ECGs who
have negative marker studies and no complica-
tions during a 12-hour observation period have
only a 1.6 per 1,000 patient risk of subsequent ad-
verse events.12,18 The present study confirms these
data. No patient had an adverse event more than
12 hours after ED arrival. Studies regarding the
safety of a nine-hour rule-out protocol followed by
stress testing in low-risk patients are forthcoming.
CONCLUSIONS
This study validates the results of the COCHPA
study. Patients presenting to the ED with cocaine-
associated chest pain have approximately a 6% in-
cidence of myocardial infarction. Given the appar-
ent low risk of complications, future studies may
find that following a short ED observational rule-
out period, stress testing in low- to intermediate-
risk patients may obviate the need for admission.
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